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Satellite cells reside beneath the basal lamina of skel-
etal muscle fibers and include cells that act as pre-
cursors for muscle growth and repair. Although
they share a common anatomical localization and
typically are considered a homogeneous population,
satellite cells actually exhibit substantial heterogene-
ity. We used cell-surface marker expression to purify
from the satellite cell pool a distinct population of
skeletal muscle precursors (SMPs) that function as
muscle stem cells. When engrafted into muscle of
dystrophin-deficient mdx mice, purified SMPs con-
tributed to up to 94% of myofibers, restoring dystro-
phin expression and significantly improving muscle
histology and contractile function. Transplanted
SMPs also entered the satellite cell compartment,
renewing the endogenous stem cell pool and par-
ticipating in subsequent rounds of injury repair. To-
gether, these studies indicate the presence in adult
skeletal muscle of prospectively isolatable muscle-
forming stem cells and directly demonstrate the effi-
cacy of myogenic stem cell transplant for treating
muscle degenerative disease.
INTRODUCTION
Skeletal muscle is a unique tissue, composed of highly special-
ized postmitotic, multinucleated fibers that contract to generate
force and movement. Muscle growth and repair depend on
a specialized subset of myofiber-associated mononuclear cells
called ‘‘satellite cells’’ (Mauro, 1961) that associate closely with
mature muscle fibers. While normally quiescent (Schultz et al.,
1978), satellite cells become activated bymuscle damage, which
causes them to proliferate and differentiate to form fusion-
competent myoblasts, which fuse with existing myofibers andone another to fully regenerate the muscle (reviewed in Hawke
and Garry, 2001; Wagers and Conboy, 2005).
Satellite cells exhibit substantial phenotypic and functional
heterogeneity, evident through differences in their cell-surface
marker expression, induction of myogenic transcription factors,
and in vivo and in vitro proliferation characteristics (Beauchamp
et al., 2000; Day et al., 2007; Rouger et al., 2004; Sherwood et al.,
2004a). However, the ability of skeletal muscle to undergo multi-
ple rounds of regeneration throughout life while still maintaining
the satellite cell pool suggests that at least a subset of satellite
cells exhibits both self-renewal and differentiation capacities—
hallmark properties of tissue stem cells (Wagers and Conboy,
2005).
Our previous work identified a unique combination of cell-
surface markers (CD45Sca-1Mac-1CXCR4+b1-integrin+,
abbreviated CSM4B) that prospectively identify autonomously
myogenic cells within the myofiber-associated satellite cell
compartment of adult mouse skeletal muscle and allow their
direct isolation by fluorescence-activated cell sorting (FACS)
(Sherwood et al., 2004a). By marker enrichment analysis, the
CSM4B subset was the only population capable of robust, clonal
myogenic differentiation in cell culture assays (Sherwood et al.,
2004a), suggesting that these skeletal muscle precursor cells
(SMPs) might represent a unique subset of canonical muscle
satellite cells that could act as self-renewing precursors for adult
skeletal muscle.
Here, we analyze the stem cell and regenerative properties of
prospectively identified SMPs. We demonstrate that uninjured
muscle SMPs express markers of resting satellite cells
(Pax7+MyoD) and lack expression of activation and myogenic
differentiation markers (MyoD and myosin heavy chain [MyHC]).
Furthermore, SMPs exhibit robust myogenic differentiation
potential, both in vitro and in vivo. Direct isolation and transplan-
tation of SMPs enables extensive reconstitution of damaged
skeletal muscle, in both immunocompetent dystrophin-deficient
mdx mice and cardiotoxin-injured wild-type mice. Importantly,
high-level engraftment of transplanted SMPs in mdx animals
shows therapeutic value—restoring defective dystrophin
gene expression, improving muscle histology, and rescuingCell 134, 37–47, July 11, 2008 ª2008 Elsevier Inc. 37
Figure 1. SMPs Express Markers of Undifferentiated Satellite Cells
(A) Double-sorted SMPs (see Figures S1 and S4) were stained with antibody against Pax7. Ninety percent (±3.2%) of freshly sorted SMP cells showed nuclear
Pax7 protein (red). Cell nuclei were marked by DAPI (blue).
(B) SMPs or CD45+ hematopoietic cells (as a negative control) were sorted from pooled limbmuscles (including EDL, TA, gastrocnemius, quadriceps, soleus, and
triceps brachii) of adult Pax3LacZ/+ heterozygous reporter mice, which express one copy of the bacterial b-galactosidase gene from the endogenous Pax3
promoter, providing a reliable reporter for Pax3 expression (Relaix et al., 2003). Double-sorted cells were stained with X-gal to detect LacZ activity and scored
as high expressers (H, see left panel), medium expressers (M, see left and middle panels), low expressers (L, see middle panel), or undetectable (U, see right
panels; cells were scored as undetectable if the level of X-gal staining was equivalent to background staining of the control CD45+ cell population, which
does not express Pax3 [data not shown]).
(C) Freshly sorted SMPswere stained as in (A) with antibody against Pax7,MyoD, Desmin, orMyHC.Most SMPs are Pax7+, and <5%wereMyoD+. No expression
of Desmin or MyHC was detected.
(D) Quantification of Pax3 expression by sorted SMPs revealed heterogeneous levels of Pax3 expression, as expected based on previous studies (Montarras
et al., 2005; Relaix et al., 2006). Data are presented as the frequency (Mean ± standard deviation [SD]) of SMP cells exhibiting high, medium, low, or undetectable
(neg.) LacZ activity.physiological muscle function. Moreover, in addition to generat-
ing mature muscle fibers, transplanted SMPs also re-seed
the satellite cell niche and are maintained there such that
they can be recruited to participate in future rounds of muscle
regeneration.
Taken together, these data indicate that SMPs act as renew-
able, transplantable stem cells for adult skeletal muscle. The
level of myofiber reconstitution achieved by these myogenic
stem cells exceeds that reported for most other myogenic cell
populations (Bachrach et al., 2006; Deasy et al., 2007; Dellavalle
et al., 2007; Dezawa et al., 2005; Qu-Petersen et al., 2002; Sam-
paolesi et al., 2003; Sherwood et al., 2004b) and leads to a strik-
ing improvement of muscle contraction function in SMP-treated
muscles. These data thus provide direct evidence that prospec-
tively isolatable, lineage-specific skeletal muscle stem cells pro-
vide a robust source of muscle replacement cells and a viable38 Cell 134, 37–47, July 11, 2008 ª2008 Elsevier Inc.therapeutic option for the treatment of muscle degenerative
disorders.
RESULTS
SMPsAre a Subset of Canonically Defined Satellite Cells
Satellite cells are classically defined by their unique anatomical
location—beneath the basal lamina and adjacent to the plasma
membrane of mature muscle fibers. Satellite cells in resting
muscle are largely quiescent (Mauro, 1961) and exhibit high-level
expression of early myogenic transcription factors, including the
paired box (Pax) protein Pax7 and, in some muscles, Pax3
(reviewed in Buckingham, 2006; Dhawan and Rando, 2005;
Wagers and Conboy, 2005). To better understand the relation-
ship of FACS-sorted CSM4B SMPs to classically defined satel-
lite cells, we analyzed their expression of myogenic transcription
Figure 2. Expression of b1-Integrin and CXCR4 by Skeletal Muscle Satellite Cells
(A) Singlemyofibers isolated from gastrocnemius or soleusmuscles of C57BLmicewere stained with anti-b1-integrin (green, top row and red,middle row) or anti-
CXCR4 (green, top and bottom rows) antibody, together with anti-laminin (red, top row) or anti-Pax7 (green, middle row and red, bottom row) and analyzed by
fluorescence microscopy. Nuclei were marked by DAPI (blue). Open arrowheads denote b1-integrin+ or CXCR4+ cells (top row). Enlarged, merged images are
shown at right (middle and bottom rows).
(B) The average frequency of Pax7 and CXCR4 or Pax7 and b1-integrin coexpression by myofiber-associated cells was determined from analysis of 60 individual
myofibers. Bar graphs depict the frequency of CXCR4-expressing (green) or b1-integrin-expressing (purple) myofiber-associated cells that also express Pax7 or
the frequency of Pax7+ cells that also express CXCR4 (blue) or b1-integrin (orange) (Mean ± SEM). The majority (80%–90%) of Pax7+ cells are also CXCR4+ and
b1-integrin+ (bottom plot). Likewise, >90% of b1-integrin+ cells are also Pax7+, although only 30% of CXCR4+ cells coexpress Pax7 (top plot). Based on flow
cytometric analysis, CXCR4+ cells that lack Pax7 expression appear for the most part to be CD45+-infiltrating inflammatory cells (data not shown), which exhibit
no myogenic activity.factors and their cell-cycle profile in the normal muscle of adult
(8–16 weeks of age) C57BL mice.
When sorted directly from resting skeletal muscle (Figure S1
available online), >90% of purified CD45Sca-1Mac-1
CXCR4+b1-integrin+ (CSM4B) SMPs showed robust expres-
sion of nuclear-localized Pax7 protein (Figures 1A and 1C),
a selective marker of primitive myogenic cells (Seale et al.,
2000), while <5% expressedMyoD (Figure 1C), a myogenic tran-
scription factor that is not expressed in quiescent satellite cells
but can be reversibly induced upon satellite cell activation
(Cornelison and Wold, 1997; Yablonka-Reuveni and Rivera,
1994; Zammit et al., 2004). One hundred percent of sorted
SMPs also costained for the surface receptors M-cadherin and
Syndecan4, previously reported to be expressed by early myo-
genic precursor cells (Cornelison et al., 2001; Cornelison and
Wold, 1997; Irintchev et al., 1994) (Figures S2A and S2B). As in
previous studies of bulk satellite cells in adult limb muscles
(Conboy and Rando, 2002; Montarras et al., 2005; Relaix et al.,
2006), SMPs harvested fresh from pooled muscles exhibited
varying levels of expression of the early myogenic transcription
factor Pax3, measured by analysis of Pax3 reporter mice ex-
pressing lacZ under control of endogenous Pax3 promoter ele-
ments (Relaix et al., 2003) (Figures 1B and 1D). Significantly,
sorted SMPs showed no detectable expression of markers ofmore differentiated muscle lineage cells, including desmin and
myosin heavy chain (MyHC) (Figure 1C), although these markers
were induced in in vitro differentiated daughter myoblasts de-
rived from clonally sorted SMPs (Figure S3). Finally, cell-cycle
analysis of sorted SMPs, using the DNA intercalating fluorescent
dye Hoechst 33342 (Ho) and the RNA-binding probe, Pyronin Y
(PY), which together provide a measure of cellular DNA content
and transcriptional activity that is reflective of cell-cycle position
(Passegue et al., 2005), indicated that <1% of CSM4B SMPs in
resting muscle are in S, G2, or M phases of the cell cycle (i.e., ex-
hibit >2N DNA content), and90%–95% of SMPs are quiescent
(in G0) (Figures S2C and S2D).
Immunostaining of isolated myofibers indicated that b1-integ-
rin+ and CXCR4+ cells were clearly detectable beneath the lam-
inin layer surrounding isolated myofibers (Figure 2A, top row). In
addition, the majority (97% ± 1%) of myofiber-associated b1-
integrin+ cells were also Pax7+ (Figures 2A, middle row and 2B,
top, purple bar). In contrast, only 30% ± 5% of CXCR4+ cells
on isolated myofibers coexpressed Pax7 (Figures 2A, bottom
row and 2B, top, green bar). (Direct costaining of CXCR4 and
b1-integrin was not possible due to antibody incompatibility.)
These data are consistent with our previous observations
(Sherwood et al., 2004a) and indicate that CXCR4, while insuffi-
cient on its own to enrich for primitive myogenic cells, providesCell 134, 37–47, July 11, 2008 ª2008 Elsevier Inc. 39
Figure 3. SMP Frequency Is Reduced in
Dystrophic Mice
Dystrophic disease in mdx animals is character-
ized by acute degeneration and regeneration of
skeletal muscle during the first month of life, fol-
lowed by a mild chronic dystrophy that begins at
6–8 weeks of age and lasts throughout life.
(A) Immunostaining for dystrophin protein in wild-
type (WT) C57BL/Ka mice reveals protein expres-
sion at the cell membrane of every myofiber. In
contrast, the majority of myofibers in mdx mice
lack dystrophin expression, with the exception of
a small number (1%–6% of total myofibers in
mice aged 10–20 weeks; Wernig et al., 2005) of
revertant fibers generated by skipping of the
mutated exon (Lu et al., 2000). Two revertant fibers
in the mdx muscle section shown are marked by
asterisks (*).
(B and C) Flow cytometric analysis of SMP fre-
quency in dystrophic mdx mice shows an 3-
fold decrease in the frequency of SMPs among
myofiber-associated cells (B) and an 2-fold
decrease among Sca-1 myofiber-associated
cells (C) harvested from mdx muscle (mean ±
SD) . *p < 0.05, **p < 0.01.
(D and E) Double-sorted SMPs frommdxmice ex-
hibited equivalent in vitro clonal plating efficiency
(D, frequency of colony formation from single cells,
as in Figure S3) and differentiation capacity (E, %
of MyHC-expressing cells after culture in differen-
tiation medium, as in Figure S3) as compared to
SMPs sorted from wild-type (WT) mice.further enrichment of Pax7+, muscle-forming precursors when
combined with b1-integrin (Sherwood et al., 2004a and
Figure S1). Significantly, 90% of myofiber-associated Pax7+
cells coexpressed b1-integrin and 80% coexpressed CXCR4
(Figures 2A and 2B, bottom, blue and orange bars), supporting
the notion that CXCR4 and b1-integrin mark a distinct subset
of Pax7+ satellite cells. Taken together, these data demonstrate
that CSM4B SMPs indeed localize to the canonical sublaminar
satellite cell niche and exhibit hallmark properties of undifferen-
tiated myogenic precursor cells, including Pax7 and Pax3
expression (Figure 1) and the capacity to autonomously generate
differentiated myocytes in clonal, myogenic cultures (Figure S3
and Sherwood et al., 2004a).
mdx Mice Exhibit Decreased Endogenous
Frequencies of SMPs
Given their relatively undifferentiated phenotype and robust
myogenic activity in vitro, we predicted that CSM4B SMPsmight
be effective mediators of muscle repair in cell transplantation
strategies. To test this hypothesis, we made use of the mdx
mouse model, which harbors a mutation in the dystrophin gene
(Dys) that results in the absence of dystrophin protein on the
majority of muscle cell membranes (Figure 3A and Lu et al.,
2000; Sicinski et al., 1989; Wernig et al., 2005). Loss of dystro-
phin expression reduces the structural integrity of mdx muscle
fibers (reviewed in Durbeej and Campbell, 2002), resulting in
repeated cycles of muscle degeneration and regeneration that
have been suggested to invoke a continual need for satellite40 Cell 134, 37–47, July 11, 2008 ª2008 Elsevier Inc.cell proliferation and cause premature loss or impairment of
myogenic activity (Blau et al., 1983; Heslop et al., 2000; Luz
et al., 2002; Wright, 1985). Interestingly, dystrophic disease in
mdx animals results in a significantly reduced in vivo representa-
tion of myogenic CSM4B SMPs within the myofiber-associated
cell compartment. This decrease in SMP frequency is detectable
as early as 12 weeks of age (Figures 3B and 3C), likely reflecting
a detrimental effect of dystrophy on maintenance of the muscle
precursor population. However, consistent with previous reports
(Yablonka-Reuveni and Anderson, 2006), sorted mdx SMPs
exhibited equivalent in vitro myogenic colony-forming activity
and efficient differentiation capacity (Figures 3D and 3E).
Transplanted SMPs Robustly Engraft Muscle In Vivo
To test the capacity of prospectively sorted SMPs to engraft in
diseased muscle and to act as a regenerative precursor popula-
tion to repair dystrophic muscle, we purified green fluorescent
protein (GFP)-expressing CSM4B SMPs (Figure S4) from pooled
limb muscles (including extensor digitorum longus [EDL], tibialis
anterior [TA], gastrocnemius, quadriceps, soleus, and triceps
brachii) of b-actin/GFP transgenic mice (Wright et al., 2001)
and injected these directly into the dystrophic muscle of 12- to
15-week-old mdx mice (which do not express GFP and show
only low numbers of dystrophin+ revertant fibers, Figure 3 and
Sicinski et al., 1989). Recipient mdx animals in these experi-
ments were preinjured by intramuscular injection of cardiotoxin
one day prior to transplant in order to enhance the muscle
regenerative response (Sherwood et al., 2004a) (Figure 4A).
Figure 4. SMPs Robustly Engraft Skeletal Muscle In Vivo
(A) Experimental design. Double-sorted GFP+ SMPs were injected intramuscularly into recipient mdx mice injured 1 day previously by injection of cardiotoxin
(CDTX) into the same muscle.
(B) Quantitative analysis of donor-derived (GFP+) myofibers in TAmuscles injected with 2000 (n = 3), 4000 (n = 3), or 11,000 (n = 3) SMPs. Recipient muscles were
harvested 4 weeks after transplantation and analyzed for GFP expression by direct epifluorescence microscopy of transverse muscle sections. The total number
of GFP+ myofibers per section was determined for 100–300 sections taken throughout the muscle, in order to determine the maximal number of donor-derived
fibers generated in eachmuscle. Data are plotted as themean (±SEM) number of GFP+myofibers detected in the section of each engraftedmuscle that contained
the most GFP+ myofibers. *p < 0.01.
(C) Transverse frozen sections of TA (left panel) and gastrocnemius (middle and right panels) muscles obtained frommdxmice transplanted 4 weeks previously
with 11,000 GFP+ SMPs showed large clusters of regenerating donor-derived myofibers (GFP+, shown in green) with characteristic centrally localized nuclei
(inset) and restored dystrophin expression (shown in red; dystrophin staining is shown on the right image only). GFP detection by epifluorescence (as in C)
was confirmed by indirect immunofluorescence and immunohistochemistry using anti-GFP antibodies (see Figure S5).
(D) Quantification of the frequency (mean ± SD) of dystrophin+ myofibers among GFP+ donor-derived myofibers in the TA or gastrocnemius of mdx mice trans-
planted with 11,000 SMP cells per muscle revealed that the majority (85%–100%) of GFP+ myofibers costained with dystrophin protein (red), which normally is
lacking on most mdx myofibers (Sicinski et al., 1989 and see Figure 3).
(E andF)Myofiber-associatedcells lackingSMPmarkersdonotgeneratemyofiberswhen transplanted in vivo.CD45Sca-1Mac-1CXCR4b1-integrin (double
negative, DN) cells or CD45Sca-1Mac-1CXCR4+b1-integrin+ SMPs were twice-sorted (to ensure purity) from b-actin/GFP mice and then transferred at equal
cell number (4000 permuscle) into separate preinjuredmdx recipients. Four weeks after transplant, injectedmuscles were harvested and sectioned. NoGFP+my-
ofibers were found in muscles transplanted with DN cells (n = 3), while muscle receiving GFP+ SMPs showed efficient contribution of GFP+ myofibers (n = 3).Engraftment of donor-derived myofibers in mdx recipients was
measured by direct epifluorescence (for GFP) and indirect immu-
nofluorescence (for dystrophin) on transverse sections of muscle
harvested 4 weeks after transplant. (GFP detection by epifluor-
escence also was confirmed by indirect immunofluorescence
and immunohistochemistry, see Figure S5.) Analyses of trans-
planted TA and gastrocnemius muscles of recipient mice re-
vealed a robust, dose-dependent engraftment of donor-derivedGFP+ myofibers (Figures 4B and 4C). Donor-engrafted GFP+
myofibers showed centrally localized nuclei (Figure 4C),
characteristic of newly regenerated myofibers, and the majority
(85%–100%) stained positively for dystrophin protein on the
myofiber membrane (Figures 4C and 4D). Additional experi-
ments suggested that transplanted SMPs contribute to muscle
regeneration both by fusion with existing myofibers and endog-
enous myocytes and by de novo myogenesis. GFP+ SMPs wereCell 134, 37–47, July 11, 2008 ª2008 Elsevier Inc. 41
Figure 5. Functional Improvement in Mus-
cle Contractile Force following Engraftment
of Wild-Type SMPs into Dystrophic Muscle
(A) Representative traces from contractile force
measurements of SMP-transplanted (top rows)
or mock-transplanted muscles. Traces are paired
showing force production from contralateral mus-
cles of the same recipient animal and are normal-
ized for muscle cross-sectional area. The % GFP+
myofibers detected upon subsequent sectioning
of each muscle is indicated above each trace.
Normalized data for all animals in the study, used
for calculation of the fold differences and regres-
sion curves shown in (B) and (C), are provided in
Table S1.
(B) Regression analysis shows a significant (p <
0.001) correlation between the fold difference
from the control in Peak Specific Force production
for the 10 min contraction protocol (plotted as the
ratio of the average Peak Specific Force in SMP-
transplanted versus mock-transplanted, contra-
lateral soleus muscle) and the % GFP+ myofibers
in the transplanted muscle. Each diamond repre-
sents data from an individual mouse (n = 16).
(C) Regression analysis shows significant (p <
0.001) correlation between the fold difference
from the control in Integrated Area Under the
Curve (amplitude 3 duration) for the 10 min con-
traction protocol (plotted as the ratio of the
average Integrated Area Under the Curve in
SMP-transplanted versus mock-transplanted,
contralateral soleus muscle) and the % GFP+ my-
ofibers in the engrafted muscle. Each diamond
represents an individual mouse (n = 16).
(D) Representative epifluorescence images showing GFP expression (green) inmyofibers of mock-transplanted (left-most panel) or SMP-transplanted (three right
panels) soleus muscles of individualmdxmice. Individual soleus muscles showed highly variable levels of engraftment, likely related to technical limitations in the
efficiency of cell delivery that arise from the small size and less accessible anatomical location of the soleus.transplanted into the muscle of related transgenic mice constitu-
tively expressing a distinct fluorescent marker (HcRed). Because
all skeletal muscle fibers in HcRed transgenic mice express
HcRed (Sherwood et al., 2004b), this transplant strategy
directly discriminates autonomously formed donor myofibers
(GFP+HcRed) from host fibers (GFPHcRed+) and from hybrid
fibers (GFP+HcRed+) formed by fusion of GFP+ precursors with
HcRed+ host myofibers. Engrafted muscles from HcRed recipi-
ents showed all three myofiber types (Figure S6A), indicating
that transplanted SMPs both fuse with existing host myocytes
and myofibers and generate myofibers de novo.
Using the data shown in Figure 4B, we estimated the efficiency
with which transplanted SMPs contribute to regenerating myo-
fibers by calculating the regeneration index (RI), defined as the
number of donor-engrafted myofibers generated per 105 trans-
planted cells (Deasy et al., 2007). This calculation yielded an RI
of 3726 ± 272 for freshly isolated SMPs, which is 5- to 40-
fold higher than RIs estimated similarly from previous reports
of cultured populations of muscle-derived stem and progenitor
cells (Bachrach et al., 2006; Deasy et al., 2007; Qu-Petersen
et al., 2002) or nonmuscle lineage cells (Dellavalle et al., 2007;
Dezawa et al., 2005; Sampaolesi et al., 2003; Sherwood et al.,
2004b) and roughly equivalent to myogenic cells identified using
genetically modified mice expressing a Pax3 reporter gene
(Montarras et al., 2005). Other populations of myofiber-associ-42 Cell 134, 37–47, July 11, 2008 ª2008 Elsevier Inc.ated cells lacking expression of SMP markers do not exhibit
this robust in vivo engraftment capacity (Figures 4E and 4F and
Sherwood et al., 2004a). SMP-derived myofibers were main-
tained in mdx hosts for up to 4 months post-transplant (the lon-
gest time point analyzed, data not shown).
SMP Engrafted Muscles Show Significant
Improvement in Contraction Function
To test whether engraftment by wild-type cells and restoration of
dystrophin expression might have a therapeutic benefit for
engrafted mdx muscles, we measured muscle force production
in previously transplanted mdx muscle as compared to mock-
transplanted muscle. 20,000 FACS-sorted GFP+ SMPs were
transplanted into one uninjured soleus muscle of each of 16
mdx recipients, while the contralateral muscle of each recipient
received PBS alone. Four weeks after transplant, intact SMP-
transplanted and mock-transplanted muscles from individual
mdx recipient mice were harvested and electrically stimulated
to contract for 10min. For each individual animal, the contraction
forces of SMP-transplanted versus mock-transplanted muscles
were measured in parallel. To compare contraction forces, the
Peak Specific Force (a measure of the initial strength of muscle
contraction) and Integrated Area Under the Curve (contraction
amplitude 3 duration, a measure that takes into account the
muscle’s initial strength as well as resistance to fatigue) were
Figure 6. Transplanted SMPs Re-seed the
Satellite Cell Compartment
(A) Intact myofibers isolated from the gastrocne-
mius and soleus muscles of previously trans-
planted mdx mice show donor-derived GFP+
Pax7+ satellite cells associated with GFP+ myofib-
ers. GFP is shown in green, Pax7 in red, and DAPI-
stained nuclei in blue. Two representative image
series are shown.
(B) Quantitative analysis of the frequency of GFP+
and GFP Pax7+ cells detected on single GFP+
myofibers isolated from previously transplanted
mdx muscles (gastrocnemius and soleus, n = 41
individual myofibers). The majority of Pax7+ cells
on GFP+ myofibers are GFP+ (Mean ± SD).
(C) Reisolation of GFP+ SMPs from the myofiber-
associated cell compartment of mdx mice trans-
planted 4 weeks previously with GFP+ SMPs.
The top contour plots depict events already gated
for forward and side-scatter, live (calcein+ propi-
dium iodide), Sca-1CD45Mac-1 cells and in-
dicates the CXCR4+b1-integrin+ SMP population,
which is further analyzed for GFP expression in
the lower plot. Greater than 1% of reisolated
SMPs were GFP+, in part due to low total numbers
of GFP+ myofibers in this particular cohort of mice
(data not shown, n = 4). GFP+ SMPs were not
detected in untransplanted control muscles (right
panels).
(D) TA muscles from a subset ofmdxmice previously transplanted with GFP+ SMPs were reinjured by cardiotoxin injection 4 weeks after transplantation. Analysis
of donor-derived myofibers was performed 1 week after injury by direct epifluorescence microscopy. Data are presented as the mean (±SD) number of GFP+ my-
ofibers detected in the section of each engraftedmuscle that contained themost GFP+myofibers (as in Figure 4). Reinjuredmuscles showed a significantly greater
number of donor-derived myofibers (n = 3), as compared to uninjured control muscles that were not reinjured (n = 3). *p < 0.05.calculated (Table S1). The fold differences in these values for
SMP-transplanted versus mock-transplanted muscle of the
same animal were used for correlation analyses. These studies
revealed a striking and significant (p < 0.001) correlation between
muscle force production and the degree of engraftment from
transplanted SMPs, with highly engrafted muscle—showing up
to 94% GFP-expressing myofibers—exhibiting up to 5.5-fold
greater force production as compared to mock-transplanted
muscle in these assays (Figures 5B and 5C and Table S1). Com-
parison to contraction forcesmeasured independently for soleus
muscles of normal, wild-type mice that were age- and sex-
matched to the transplant recipients revealed that engrafted
mdx animals showing >25% GFP+ fibers exhibited average
Peak Specific Forces approaching those of nondystrophic ani-
mals (29.5 ± 2.7 mN/mm2 versus 31.47 ± 7.06 [mean ± SEM]
mN/mm2). Interestingly, although donor SMPs for these experi-
ments were purified primarily from ‘‘fast-twitch’’ muscle (con-
taining predominantly type II myofibers), the engrafted fibers
showed a mixed distribution of ‘‘fast-twitch’’ and ‘‘slow-twitch’’
(type I) fibers characteristic of the soleus muscle into which
they were implanted (Figure S6B). These data confirm the dom-
inance of themuscle environment in specifying fiber type (Collins
et al., 2005) and rule out the possibility that a transplant-induced
change in muscle fiber type is responsible for the improved
muscle contraction force.
Taken together, these data clearly demonstrate the capacity
of prospectively identified muscle-resident precursor cells to
differentiate robustly and selectively to regenerate mature, func-tional myofibers when transplanted into injured or damaged
muscle. Remarkably, in some animals, transplanted SMPs sup-
ported nearly complete chimerism ofmyofibers, and these highly
engrafted muscles (typically those showing >25%GFP+ myofib-
ers) exhibited striking improvements in physiologic function
(Figure 5). We observed widespread contributions of trans-
planted SMPs to mature muscle fibers and improved histology
in SMP engrafted muscles, both with and without cardiotoxin
pretreatment, indicating that highly ablative preconditioning is
not necessary to achieve therapeutic muscle engraftment in
dystrophic muscles (Figures 4, 5, and S7).
Transplanted SMPs Functionally Re-engraft
the Satellite Cell Niche
The robust regenerative activity of SMPs requires no intervening
cell culture (Deasy et al., 2007; Dellavalle et al., 2007; Dezawa
et al., 2005), or genetic manipulation (Dezawa et al., 2005; Kuang
et al., 2007), and on a per cell basis appears to exceed the
engraftment efficiencies of most previously described popula-
tions of muscle cells or other cell types (Bachrach et al., 2006;
Deasy et al., 2007; Dezawa et al., 2005; Morgan et al., 1993;
Qu-Petersen et al., 2002; Wernig et al., 2005). However, an ideal
cell for muscle therapy must also be capable of repopulating the
precursor cell pool, providing an enduring source of regenerative
cells for muscle repair after injury. We therefore tested the ability
of transplanted SMPs to re-enter and renew within the satellite
cell compartment and to be recruited for subsequent rounds of
regenerative myogenesis. For these studies, mdx mice wereCell 134, 37–47, July 11, 2008 ª2008 Elsevier Inc. 43
preinjured by cardiotoxin injection and transplanted with GFP+
SMPs. Four weeks later, SMP-transplanted muscles, or mock-
transplanted control muscles, were harvested and analyzed for
engraftment of donor cells into the satellite cell compartment.
Single myofibers harvested from engrafted recipients were
stained for Pax7 to reveal myofiber-associated satellite cells
on donor-engrafted (GFP+) myofibers. Strikingly, the majority of
Pax7+ cells found on GFP+ myofibers from previously trans-
planted mdx gastrocnemius and soleus muscles exhibited
coexpression of GFP, indicating that most of the satellite cells
on these myofibers derived from the previously transplanted
SMPs (Figures 6A and 6B). In addition, FACS analysis of enzy-
matically prepared myofiber-associated cells isolated from gas-
trocnemius and soleus muscles of grafted mdx mice showed
a clearly distinguishable population of GFP+ SMPs within previ-
ously transplanted mdx muscle (Figure 6C). Transplanted GFP+
SMPs not only gave rise to cells that retained the SMP pheno-
type but also generated CXCR4b1-integrin+ and CXCR4b1-
integrin cells (Figure S9), suggesting that these represent the
progeny of primitive SMPs. Finally, to assess the capacity of
the engrafted SMP population to be recruited again to partici-
pate in subsequent rounds of muscle repair, we reinjured the
muscles of mdx mice previously transplanted with GFP+ SMPs
by a second intramuscular injection of cardiotoxin and com-
pared the numbers of donor-derived (GFP+) myofibers found in
reinjured muscles to those found in previously transplanted
muscles that were not reinjured. Consistent with ongoing
participation of the engrafted donor cells in muscle repair and
regeneration, reinjured muscles showed a significantly higher
contribution of GFP+ myofibers when compared to identically
transplanted muscles that were not reinjured (Figure 6D). Taken
together, these data clearly indicate that in vivo transplantation
of prospectively identified SMPs not only allows reconstitution
of mature muscle fibers but also replenishes the primitive muscle
precursor pool, thus seeding a reserve pool of muscle regenera-
tive cells that can be recruited for subsequent rounds of muscle
growth and repair.
DISCUSSION
Stem cells are present in many adult tissues, where they play an
important role in postnatal growth and tissue regeneration. Our
data in mice demonstrate that direct cell sorting using a distinct
combination of cell-surface markers allows the prospective
identification of a novel subset of skeletal muscle satellite cells
that exhibits properties of adult muscle stem cells. SMPs are
committedmyogenic precursor cells, isolated by negative selec-
tion for the cell-surface markers CD45, Sca1, and Mac1 and
positive selection for b1-integrin and CXCR4. Unlike previous
approaches (Dezawa et al., 2005; Kuang et al., 2007; Montarras
et al., 2005; Sampaolesi et al., 2003), isolation of SMPs is based
on normally expressed cell-surface markers and therefore is
broadly applicable to accomplish direct muscle stem cell isola-
tion and analysis from different mouse strains and ages without
the need for specialized transgenic lines or extended periods of
cell culture.
To examine the therapeutic potential of SMPs, we conducted
transplant studies intomdxmice, amodel of DuchenneMuscular44 Cell 134, 37–47, July 11, 2008 ª2008 Elsevier Inc.Dystrophy. Wild-type GFP+ SMPs contributed robustly to the
regeneration of mature muscle fibers in recipient mice at a fre-
quency that was directly proportional to the number of precursor
cells injected and that in some recipients approached complete
donor chimerism for myofibers (Figure 5). Engraftment of wild-
type SMPs into mdx muscle thus provides a highly effective
mechanism for the introduction of the dystrophin gene into
dystrophin-deficient muscle, consequently restoring dystrophin
protein expression on themajority of myofibers (Figure 4), reduc-
ing muscle inflammation and fibrosis (Figure S7B), and signifi-
cantly improving physiological muscle function (Figure 5).
In addition to participating in the repair of differentiatedmuscle
fibers, transplanted SMPs also re-enter the satellite cell niche,
contributing the majority of Pax7+ cells found on donor-derived
myofibers (Figure 6). These engrafted precursor cells could be
recruited to participate again in the repair of future muscle injury
(Figure 6D). The high level of contribution of donor GFP+
SMPs to mature GFP+ myofibers and to the pool of satellite
cells associated with GFP+ fibers likely reflects both unique, cell-
autonomous properties of the SMP population as well as cell-
nonautonomous aspects of the transplant model. Specifically,
the lower endogenous frequency of SMPs in mdx muscle
(Figure 3) and the cytotoxic effects of cardiotoxin pretreatment
on SMP numbers (Figure S8) may lessen potential competition
from endogenous cells during transplant and facilitate high-level
contribution of the introduced GFP+ cells. Alternatively, cardio-
toxin pretreatment may induce or enhance production of SMP
support factors and provide a more conducive environment for
myogenic engraftment. However, it is important to note that
muscle engraftment by SMPs was not dependent on highly
ablative preinjury, as these cells also contributed at high effi-
ciency (up to 94% of total myofibers) after transfer into uninjured
muscle (Figures 5 and S7). In addition, recipient immunosup-
pression (Montarras et al., 2005) was not necessary for high-level
SMP engraftment or for maintenance of grafted fibers for up to
4 months (data not shown). Thus, robust donor cell engraftment
can be achieved in fully immunocompetent animals and can be
maintained for extended periods of time following SMP trans-
plant in mice, which should encourage investigation of analo-
gous strategies for cell replacement therapy in humans.
Taken together, these data demonstrate that, like hematopoi-
etic stem cells in the bone marrow (Kondo et al., 2003), SMPs
represent a transplantable population of tissue-specific stem
cells that can undergo self-renewing proliferation as well as line-
age-selective differentiation in response to injury. Notably, this
capacity for enduring regenerative function is a unique activity
of this distinct subset of primitive muscle stem cells and is not
provided by their more differentiated daughters (Figures 4E
and 4F), a finding that helps to explain themodest clinical benefit
observed in earlier studies employing transplantation of differen-
tiated myoblasts for the treatment of muscle degenerative dis-
ease (Miller et al., 1997; Peault et al., 2007). Thus, even in tissues
composed of typically very long-lived progeny—like the skeletal
muscle—stem cells appear to exhibit specialized activities,
uniquely providing robust engraftment and long-term contribu-
tion to tissue regeneration. While the singular properties of
muscle stem cells that are critical for these important activities
remain largely undiscovered (as is the case for most stem cell
populations identified to date), stem cell-specific attributes, in-
cluding their ability to generate large numbers of progeny, their
extensive self-renewal potential, or other more poorly under-
stood characteristics (such as their ability to home to appropriate
niches or to sense environmental signals), likely promote their
robust regenerative activity. The ability to prospectively identify
and directly purify muscle stem cells (SMPs) from both normal
and diseased skeletal myofibers will be a tremendous benefit
for the future elucidation of both the normal processes that con-
trol muscle specification and the ways in which these processes
are deregulated by disease. Such studies ultimately will build
a molecular portrait of the positive and negative regulatory path-
ways controlling adult myogenesis and will enable more refined
interventions to enhance muscle function by restoring appropri-
ate numbers and endogenous activity of these cells, which can
be significantly perturbed by injury, disease, and aging (Figure 3
and Blau et al., 1983; Conboy et al., 2003; Conboy et al., 2005;
Luz et al., 2002; Wright, 1985). Finally, as demonstrated here, di-
rect transplantation of highly purified muscle stem cells repre-
sents a promising therapeutic option for muscle degenerative
disorders, as these cells provide an effective source of immedi-
ately availablemuscle regenerative cells aswell as a reserve pool
that can maintain muscle regenerative activity in response to
future challenges.
EXPERIMENTAL PROCEDURES
Mice
These studies used adult (8–16 weeks of age) C57BL/Ka mice, mdx mice
(C57BL/10ScSn-Dmdmdx, purchased from Jackson Laboratories, Bar Harbor,
ME, USA), FVB Pax3LacZ/+ heterozygous mice (Relaix et al., 2003), or GFP
transgenic (C57BL/Ka-b-actin-EGFP [Wright et al., 2001]) or HcRed transgenic
(C57BL/Ka-b-actin-HcRed [Sherwood et al., 2004a, 2004b]) mice, in which
cytoplasmic GFP or HcRed, respectively, is expressed from the ubiquitous
chicken b-actin promoter. Mice were maintained at the Joslin Diabetes Center
and Harvard School of Public Health animal facilities according to institution-
ally approved protocols.
Single Myofiber and SMP Isolation
Single myofibers and myofiber-associated cells were prepared from intact
limb muscles (EDL, gastrocnemius, quadriceps, soleus, TA, and triceps bra-
chii), essentially as described (Conboy et al., 2003; Sherwood et al., 2004a).
After isolation, myofiber-associated cells were stained for isolation by FACS
of particular cell populations (see below). Markers for SMP isolation were
CD45Sca-1Mac-1CXCR4+b1-integrin+ (Sherwood et al., 2004a). We
typically obtain 50,000 SMPs per gram of muscle from uninjured, 8- to
12-week-old wild-type mice.
Flow Cytometry
Flow cytometry analysis and cell sorting were performed at the Joslin Diabetes
Center/Harvard Stem Cell Institute Flow Cytometry Core. Both sorting and
analysis were carefully optimized for antibody titration and to achieve maximal
cell purity and viability. Staining was performed as in Sherwood et al. (2004a).
Antibody titrations and suppliers are available online in the Supplemental Data.
Pax3 Expression Analysis
Sorted SMP cells or CD45+ hematopoietic cells from Pax3LacZ/+ heterozygous
mice were fixed in 4% paraformaldeyhyde and incubated overnight at 37C
with X-gal (Sigma) to determine LacZ expression.
Tissue Injury
For injections into the TA and gastrocnemiuis muscles, anesthetized mice
were injected with 25 ml (0.03 mg/ml) of Naja mossambica mossambica cardi-otoxin (Sigma) 1 day before cell transplantation. The next day, double-sorted
cells, in 5–10 ml PBS were injected directly into these preinjured muscles. For
soleus injections, muscles were not preinjured before cell injection. The skin
and fascia of anesthetized recipients were opened at the lateral aspect of
the lower leg, and the gastrocnemius moved aside to expose the soleus for
injection. Cells were delivered directly into the soleus, and the wound was
closed with clips or suture. Injected TA, gastrocnemius, and soleus muscles
were analyzed 4 weeks or 4 months after transplant.
Immunostaining
Staining of fixed (4% paraformaldeyhyde), frozen muscle sections (5–8 mm
thick) was performed as in Sherwood et al. (2004a). GFP was detected micro-
scopically by epifluorescence, immunofluorescence, or immunohistochemis-
try. Sorted SMP cells were fixed in 4% paraformaldehyde, permeabilized in
0.2% Triton X-100/PBS (Sigma), then blocked and stained as for muscle
sections. For immunostaining of individual myofibers, gastrocnemius and
soleus muscles were harvested, fixed (4% paraformaldeyhyde, 1 hr), and
washed with PBS. Muscles were individually homogenized (T25 Basic tissue
homogenizer, Kika Labortechnik, Staufen, Germany) at 8000 rpm in 15 ml
PBS, replacing the fiber suspension every 15 s with fresh PBS. Isolated fibers
were permeabilized with 0.2% Triton X-100/PBS, blocked with 50:50 MOM
Blocking (Vector Labs) and 10% horse serum/5% nonfat dried milk/4% BSA
inPBS, and stained as above,with the indicated antibodies.Antibody titrations,
suppliers, and details of staining are provided as Supplemental Data online.
Microscopy
Fluorescence and brightfield images were acquired using a standard Olympus
BX60microscope or Zeiss LSM510META confocal microscope (offering three
visible wavelength lasers Argon/2 458, 477, 488, 514; HeNe1 543, and HeNe2
633; and two-photon capability, as well as META spectral emission detectors,
which can separate strongly overlapping fluorescence emission spectra).
Standard fluorescence images were acquired using DP Manager (Olympus
Optical CO, LTD), and confocal images were acquired using Zeiss LSM Image
Browser. To confirm GFP signals and exclude autofluorescence artifacts, we
conducted spectral analysis (as in Jackson et al., 2004 and Swenson et al.,
2007) on muscle sections and single isolated myofibers. Spectral images
were acquired at 10.5 nm intervals from 477 nm to 702 nm and confirmed
that engrafted tissues showed intensity profiles characteristic of GFP (peaking
at 509 nm), while control tissues exposed identically (pinhole 112 mm) showed
no detectable fluorescence (data not shown).
Muscle Force Production
Mice were sacrificed by cervical dislocation, and soleus muscles rapidly ex-
cised. Resting muscle length was measured with a micrometer, and muscles
attached to a tissue support with stimulating electrodes. Muscles were bathed
in Krebs-Ringer-Bicarbonate buffer containing (in mM): 117 NaCl, 4.7 KCl,
2.5 CaCl22H2O, 1.2 KH2PO4, 1.2 MgSO47H2O, 24.6 NaHCO3, 1.2 glucose,
and oxygen bubbled for 10 min. Optimal muscle length was determined for
eachmuscle by increasing the resting tension in 0.2 g increments and applying
a single electrical pulse generated by a Grass stimulator (Harvard Apparatus,
Holliston,MA,USA) (parameters: pulse rate = 1 pulse/s; duration = 1ms; volts =
100 V). Force production was monitored using an isometric force transducer
(Kent Scientific, Litchfield, CT, USA), and the converted digital signal captured
by a data acquisition system (iWorx114, CB Sciences, Dover, NH) and
assessed with analysis software (Labscribe, CB Sciences, Dover, NH, USA).
The resting tension at which peak force was achieved was the tension applied
just prior to the muscle fatigue protocol.
Muscle force production was assessed by maximally stimulating muscles
for 10 min (parameters: train rate = 2/min; train duration = 10 s; pulse rate =
100 pulses/s; duration = 0.1 ms; volts = 100 V). Specific force was calculated
by normalizing force measurements to total muscle cross-sectional area
(CSA). Total CSA was determined by dividing muscle weight by the product
of the muscle length and the average density of mammalian skeletal muscle
(1.06 mg/mm3). The average Peak Specific Force over the 10 min protocol
and the average Integrated Area Under the Curve (contraction amplitude 3
duration) over the 10 min protocol were used separately for correlation
analyses.Cell 134, 37–47, July 11, 2008 ª2008 Elsevier Inc. 45
Statistical Analysis
Results were assessed for statistical significance using Student’s t test (Micro-
soft Excel) or by regression analysis (SigmaPlot 2000), as indicated.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, nine fig-
ures, and one table and can be found with this article online at http://www.cell.
com/cgi/content/full/134/1/37/DC1/.
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